AMANDA ROWE: Open Payments
NPI 1265893952 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 59 payments from 21 companies in 2025. Trend: 2023 $1,192 · 2024 $1,047 · 2025 $1,087
Food & beverage: $1,087
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $231 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $116 |
| Exact Sciences Corporation | 6 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $82 |
| Lilly USA, LLC | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $68 |
| PFIZER INC. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 4 | $43 |
| Novo Nordisk Inc | 2 | $32 |
Products named: CAPLYTA, VRAYLAR, DALVANCE, Kerendia, REXULTI, XIFAXAN, MOUNJARO, Cologuard Collection Kit.
Industry payments across AL — which companies pay providers there.
